Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_assertion type Assertion NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_head.
- NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_assertion description "[In summary, KRAS G12C mutations, TTF-1, and napsin A were associated with primary lung adenocarcinoma, whereas KRAS G12R mutations, CK20, and CDX2 favored pancreatic adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_provenance.
- NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_assertion evidence source_evidence_literature NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_provenance.
- NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_assertion SIO_000772 23887294 NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_provenance.
- NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_assertion wasDerivedFrom befree-2016 NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_provenance.
- NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_assertion wasGeneratedBy ECO_0000203 NP1096855.RAHUts3k7Dh79cOSrvpWiKx6HaBXfGzH0P5HJRuxGbavY130_provenance.